Hepatocellular Carcinoma Clinical Trials in Busan
5 recruitingBusan, South Korea
Showing 1–5 of 5 trials
Recruiting
Phase 1
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Metastatic Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
Alnylam Pharmaceuticals158 enrolled23 locationsNCT06600321
Recruiting
Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma
AstraZeneca1,220 enrolled204 locationsNCT06921785
Recruiting
Phase 1
A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Hepatocellular Carcinoma
Myeloid Therapeutics70 enrolled9 locationsNCT06478693
Recruiting
Imjudo & Imfinzi PMS
Hepatocellular Carcinoma
AstraZeneca246 enrolled6 locationsNCT06544629
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Rznomics, Inc.45 enrolled9 locationsNCT06695026